Terms: = Lymphoma AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO
144 results:
1. A pyrazolopyridine as a novel AhR signaling activator with anti-breast cancer properties in vitro and in vivo.
Abduh MS; Alwassil OI; Aldaqal SM; Alfwuaires MA; Farhan M; Hanieh H
Biochem Pharmacol; 2024 Apr; 222():116079. PubMed ID: 38402910
[TBL] [Abstract] [Full Text] [Related]
2. PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma.
Shi Y; Mi L; Lai Y; Zhao M; Jia L; Du T; Song Y; Li X
J Hematop; 2023 Mar; 16(1):7-16. PubMed ID: 38175373
[TBL] [Abstract] [Full Text] [Related]
3. Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
Conter V; Valsecchi MG; Cario G; Zimmermann M; Attarbaschi A; Stary J; Niggli F; Dalla Pozza L; Elitzur S; Silvestri D; Locatelli F; Möricke A; Engstler G; Smisek P; Bodmer N; Barbaric D; Izraeli S; Rizzari C; Boos J; Buldini B; Zucchetti M; von Stackelberg A; Matteo C; Lehrnbecher T; Lanvers-Kaminsky C; Cazzaniga G; Gruhn B; Biondi A; Schrappe M
J Clin Oncol; 2024 Mar; 42(8):915-926. PubMed ID: 38096462
[TBL] [Abstract] [Full Text] [Related]
4. L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes.
Schlichtner S; Yasinska IM; Klenova E; Abooali M; Lall GS; Berger SM; Ruggiero S; Cholewa D; Milošević M; Gibbs BF; Fasler-Kan E; Sumbayev VV
Oncoimmunology; 2023; 12(1):2244330. PubMed ID: 37577144
[TBL] [Abstract] [Full Text] [Related]
5. Mitochondrial DNA Fragmentation and Risk of Non-Hodgkin lymphoma.
Hosgood HD; Davitt M; Cawthon R; Weinstein SJ; Blechter B; Wong JYY; Rahman ML; Hu W; Männistö S; Albanes D; Rothman N; Lan Q
JAMA Netw Open; 2023 Aug; 6(8):e2326885. PubMed ID: 37531109
[TBL] [Abstract] [Full Text] [Related]
6. Granulomatosis with polyangiitis presenting as a solitary renal mass: a case report.
Higashihara M; Kawamura T; Miyazaki Y; Yokoo T; Joh K
BMC Nephrol; 2023 Jul; 24(1):223. PubMed ID: 37507681
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients.
Lin L; Barkman HJ; Smit EF; de Langen AJ; Steeghs N; Beijnen JH; Huitema ADR
Ther Drug Monit; 2024 Feb; 46(1):73-79. PubMed ID: 37348074
[TBL] [Abstract] [Full Text] [Related]
8. The burden of childhood and adolescent cancers in North Africa and the Middle East (NAME) region: findings from the Global Burden of Disease study 2019.
Karimi A; Saeedi Moghaddam S; Azadnajafabad S; Esfahani Z; Sharifnejad Tehrani Y; Abbasi-Kangevari M; Shobeiri P; Ghamari SH; Masinaei M; Rezaei N; Shahin S; Rayzan E; Rezaei N; Larijani B; Kompani F
BMC Pediatr; 2023 Mar; 23(1):113. PubMed ID: 36890483
[TBL] [Abstract] [Full Text] [Related]
9. Direct interaction between mortalin and HIF-1α at the mitochondria inhibits apoptosis by blocking recruitment of Bax.
Yfantis A; Mylonis I; Simos G
FEBS J; 2023 Aug; 290(15):3764-3780. PubMed ID: 36825991
[TBL] [Abstract] [Full Text] [Related]
10. Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission.
Kowada A
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011129. PubMed ID: 36809372
[TBL] [Abstract] [Full Text] [Related]
11. Milk consumption and risk of twelve cancers: A large-scale observational and Mendelian randomisation study.
Lumsden AL; Mulugeta A; Hyppönen E
Clin Nutr; 2023 Jan; 42(1):1-8. PubMed ID: 36473423
[TBL] [Abstract] [Full Text] [Related]
12. Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The Netherlands.
Ector GICG; Geelen IGP; Dinmohamed AG; Hoogendoorn M; Westerweel PE; Hermens RPMG; Blijlevens NMA
Leuk Lymphoma; 2023 Feb; 64(2):424-432. PubMed ID: 36369821
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Profiling Reveals Differences in Primary Central Nervous System lymphoma and Large B-Cell lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
Severson EA; Haberberger J; Hemmerich A; Huang RSP; Edgerly C; Schiavone K; Najafian A; Hiemenz M; Lechpammer M; Vergilio JA; Lesser G; Strowd R; Elvin J; Ross JS; Hegde P; Alexander B; Singer S; Ramkissoon S
Oncologist; 2023 Jan; 28(1):e26-e35. PubMed ID: 36342081
[TBL] [Abstract] [Full Text] [Related]
14. Hepatitis E Virus Infection in Cancer Patients.
Chiu CY; Zhang HC; Westin J; Hosing C; Torres HA
Transplant Cell Ther; 2022 Nov; 28(11):788.e1-788.e5. PubMed ID: 36031077
[TBL] [Abstract] [Full Text] [Related]
15. Unconventional Oil and Gas Development Exposure and Risk of Childhood Acute Lymphoblastic Leukemia: A Case-Control Study in Pennsylvania, 2009-2017.
Clark CJ; Johnson NP; Soriano M; Warren JL; Sorrentino KM; Kadan-Lottick NS; Saiers JE; Ma X; Deziel NC
Environ Health Perspect; 2022 Aug; 130(8):87001. PubMed ID: 35975995
[TBL] [Abstract] [Full Text] [Related]
16. Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
Cockrum RH; Soo J; Ham SA; Cohen KS; Snow SG
Obstet Gynecol; 2022 Sep; 140(3):477-487. PubMed ID: 35926206
[TBL] [Abstract] [Full Text] [Related]
17. 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL.
Santanelli di Pompeo F; Clemens MW; Atlan M; Botti G; Cordeiro PG; De Jong D; Di Napoli A; Hammond D; Haymaker CL; Horwitz SM; Hunt K; Lennox P; Mallucci P; Miranda RN; Munhoz AM; Swanson E; Turner SD; Firmani G; Sorotos M
Aesthet Surg J; 2022 Oct; 42(11):1262-1278. PubMed ID: 35639805
[TBL] [Abstract] [Full Text] [Related]
18. The sellar region as presenting theater for hematologic malignancies-A 17-year single-center experience.
Pekic S; Stojanovic M; Manojlovic Gacic E; Antic D; Milojevic T; Milicevic M; Stanimirovic A; Doknic M; Miljic D; Banjalic S; Jovanovic M; Jemuovic Z; Nikolic Djurovic M; Grujicic D; Popovic V; Petakov М
Endocr J; 2022 Sep; 69(9):1079-1090. PubMed ID: 35400679
[TBL] [Abstract] [Full Text] [Related]
19. [Changes of Serum Complement C1q in Patients with Multiple Myeloma].
Gui CS; Liu SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):506-510. PubMed ID: 35395987
[TBL] [Abstract] [Full Text] [Related]
20. Causal Association between Chronic Kidney Disease and Risk of 19 Site-Specific Cancers: A Mendelian Randomization Study.
Tang L; Li C; Chen W; Zeng Y; Yang H; Hu Y; Song H; Zeng X; Li Q; Fu P
Cancer Epidemiol Biomarkers Prev; 2022 Jun; 31(6):1233-1242. PubMed ID: 35333923
[TBL] [Abstract] [Full Text] [Related]
[Next]
